Pharmacomicrobiomics: The Gut Microbiome as a Critical Variable in Clinical Drug Response
By: Sebesi Hanna, Man Adrian and Bán Erika-Gyöngyi
References
- Gronich N, Geva-Zatorsky N, Herren R, Kelly L, Cohen Z, Zhou H, et al. Pharmacomicrobiomics. Clin Pharmacol Ther. 2025;118(6):1366–77. doi:10.1002/cpt.70066
- Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet. 2002;41(10):751–90. doi:10.2165/00003088-200241100-00005 PubMed PMID: 12162761.
- Wang S, Ju D, Zeng X. Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era. Biomedicines. 2024 Jan 16;12(1):194. doi:10.3390/biomedicines12010194 PubMed PMID: 38255298; PubMed Central PMCID: PMC10813426.
- Wilson ID, Nicholson JK. Gut Microbiome Interactions with Drug Metabolism, Efficacy and Toxicity. Transl Res J Lab Clin Med. 2017 Jan;179:204–22. doi:10.1016/j.trsl.2016.08.002 PubMed PMID: 27591027; PubMed Central PMCID: PMC5718288.
- Haiser HJ, Seim KL, Balskus EP, Turnbaugh PJ. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes. 2014 Mar 1;5(2):233–8. doi:10.4161/gmic.27915 PubMed PMID: 24637603; PubMed Central PMCID: PMC4063850.
- Rekdal VM, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019;364(6445):eaau6323. doi:10.1126/science.aau6323 PubMed PMID: 31196984; PubMed Central PMCID: PMC7745125.
- Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017 Sep 15;357(6356):1156–60. doi:10.1126/science.aah5043 PubMed PMID: 28912244; PubMed Central PMCID: PMC5727343.
- Guo Y, Crnkovic CM, Won KJ, Yang X, Lee JR, Orjala J, et al. Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites. Drug Metab Dispos. 2019 Mar;47(3):194–202. doi:10.1124/dmd.118.084772 PubMed PMID: 30598508; PubMed Central PMCID: PMC6367689.
- Kim TH, Shin S, Landersdorfer CB, Chi YH, Paik SH, Myung J, et al. Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans. AAPS J. 2015 May 20;17(5):1210–23. doi:10.1208/s12248-015-9764-2 PubMed PMID: 25990964; PubMed Central PMCID: PMC4540730.
- Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998 Jun;34(6):429–55. doi:10.2165/00003088-199834060-00002 PubMed PMID: 9646007.
- Lim YJ, Yang CH. Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy. Clin Endosc. 2012 Jun;45(2):138–44. doi:10.5946/ce.2012.45.2.138 PubMed PMID: 22866254; PubMed Central PMCID: PMC3401617.
- Martha L, Nakata A, Furuya S, Liu W, Zhang X, Mizoi K, et al. Transporter and metabolic enzyme-mediated intra-enteric circulation of SN-38, an active metabolite of irinotecan: A new concept. Biochem Biophys Res Commun. 2023 Jul 12;665:19–25. doi:10.1016/j.bbrc.2023.04.109
- Kesavelu D, Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis. 2023 Feb 24;10:20499361231154443. doi:10.1177/20499361231154443 PubMed PMID: 36860273; PubMed Central PMCID: PMC9969474.
- Augustynowicz G, Lasocka M, Szyller HP, Dziedziak M, Mytych A, Braksator J, et al. The Role of Gut Microbiota in the Development and Treatment of Obesity and Overweight: A Literature Review. J Clin Med. 2025 Jul 11;14(14). doi:10.3390/jcm14144933
- Lekang K, Shekhar S, Berild D, Petersen FC, Winther-Larsen HC. Effects of different amoxicillin treatment durations on microbiome diversity and composition in the gut. PLOS ONE. 2022 Oct 27;17(10):e0275737. doi:10.1371/journal. pone.0275737 PubMed PMID: 36301847; PubMed Central PMCID: PMC9612567.
- Youmshajekian L. Scientific American [Internet]. [cited 2026 Apr 28]. Antibiotics may mess up a person’s gut for years, study finds. Available from: https://www.scientificamerican.com/article/a-single-course-of-antibiotics-may-reshape-thegut-microbiome-for-years/
- Xue L, Ding Y, Qin Q, Liu L, Ding X, Zhou Y, et al. Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery. Front Cell Infect Microbiol. 2023 Jan 19;12:1043971. doi:10.3389/fcimb.2022.1043971 PubMed PMID: 36741975; PubMed Central PMCID: PMC9896080.
- Santaniello U, Mastorino L, Pala V, Rosset F, Crespi O, Quaglino P, et al. Pharmacomicrobiomics in Psoriasis: Microbiome-Drug Interactions Across Systemic Treatments. Life. 2026 Mar 4;16(3):415. doi:10.3390/life16030415 PubMed PMID: 41900935; PubMed Central PMCID: PMC13028330.
- Gantar K, Škerget K, Mochkin I, Bajc A. Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus. Drug Healthc Patient Saf. 2020;12:151–60. doi:10.2147/DHPS. S256455 PubMed PMID: 32982466; PubMed Central PMCID: PMC7489937.
- Qiu CC, Caricchio R, Gallucci S. Triggers of Autoimmunity: The Role of Bacterial Infections in the Extracellular Exposure of Lupus Nuclear Autoantigens. Front Immunol. 2019 Nov 8;10:2608. doi:10.3389/fimmu.2019.02608
- Slattery J, MacFabe DF, Frye RE. The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood. Clin Med Insights Pediatr. 2016 Oct 9;10:91–107. doi:10.4137/CMPed.S38338 PubMed PMID: 27774001; PubMed Central PMCID: PMC5063840.
- Björkqvist O, Rangel I, Serrander L, Magnusson C, Halfvarson J, Norén T, et al. Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection. PLoS ONE. 2021 Apr 9;16(4):e0249861. doi:10.1371/journal.pone.0249861 PubMed PMID: 33836037; PubMed Central PMCID: PMC8034738.
- Zhang Y, Mo C, Ai P, He X, Xiao Q, Yang X. Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease. Gut Microbes. 17(1):2454937. doi:10.1080/19490976.2025.2454937 PubMed PMID: 39875349; PubMed Central PMCID: PMC11776486.
- LoGuidice A, Wallace BD, Bendel L, Redinbo MR, Boelsterli UA. Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice. J Pharmacol Exp Ther. 2012 May;341(2):447–54. doi:10.1124/jpet.111.191122 PubMed PMID: 22328575; PubMed Central PMCID: PMC3336811.
DOI: https://doi.org/10.2478/orvtudert-2026-0002 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Language: English
Page range: 15 - 25
Published on: Jul 11, 2026
Published by: Transylvanian Museum Society
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Sebesi Hanna, Man Adrian, Bán Erika-Gyöngyi, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.